Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biomarin Pharmaceuticals
(NQ:
BMRN
)
87.34
-1.27 (-1.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,027,708
Open
88.34
Bid (Size)
85.23 (1)
Ask (Size)
89.23 (1)
Prev. Close
88.61
Today's Range
87.07 - 87.39
52wk Range
76.02 - 100.38
Shares Outstanding
183,352,255
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
While growth is established for NASDAQ:BMRN, the stock's valuation remains reasonable.
March 18, 2024
Despite its growth, BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) remains within the realm of affordability.
Via
Chartmill
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
March 16, 2024
Although the Nasdaq Composite is galloping to record highs, amazing deals among growth stocks can still be uncovered.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Performance
YTD
-10.92%
-10.92%
1 Month
-3.68%
-3.68%
3 Month
-10.08%
-10.08%
6 Month
-2.14%
-2.14%
1 Year
-7.28%
-7.28%
More News
Read More
Investors seeking growth at a reasonable cost should explore NASDAQ:BMRN.
February 26, 2024
Via
Chartmill
The Latest Analyst Ratings For Biomarin Pharmaceutical
February 23, 2024
Via
Benzinga
Recap: Biomarin Pharmaceutical Q4 Earnings
February 22, 2024
Via
Benzinga
7 Biotech Stocks Fighting America’s Deadliest Diseases
February 08, 2024
Via
InvestorPlace
Decoding 8 Analyst Evaluations For Biomarin Pharmaceutical
January 30, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical
December 21, 2023
Via
Benzinga
Earnings Outlook For Biomarin Pharmaceutical
October 31, 2023
Via
Benzinga
3 No-Brainer Stocks to Buy With $200 Right Now
February 07, 2024
Via
The Motley Fool
4 Marvelous Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
January 20, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
January 10, 2024
Via
InvestorPlace
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
December 02, 2023
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
November 09, 2023
Via
InvestorPlace
15 Analysts Have This to Say About Biomarin Pharmaceutical
October 16, 2023
Via
Benzinga
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
Via
InvestorPlace
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake
November 07, 2023
Via
Investor's Business Daily
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
November 07, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
4 Unique Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
November 04, 2023
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?
October 27, 2023
Via
Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2023
October 19, 2023
Via
The Motley Fool
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
September 28, 2023
Via
Benzinga
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
4 Awe-Inspiring Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 23, 2023
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.